Stockpolly
Search
Delisting risk
UPC · NASDAQ · Drug Manufacturers - Specialty & Generic

Universe Pharmaceuticals (UPC)

Manufactures traditional Chinese medicines and distributes third-party pharmaceutical and medical products across China.

$4.37
Pre-market−0.43 (−8.96%)
At close$4.80(+12.41%)
Watchlist

In millions of USD, except per-share figures

In millionsQ4 FY20Sep 2020Q2 FY21Mar 2021Q4 FY21Sep 2021Q2 FY22Mar 2022Q4 FY22Sep 2022Q2 FY23Mar 2023Q4 FY23Sep 2023Q2 FY24Mar 2024Q4 FY24Sep 2024Q2 FY25Mar 2025Q4 FY25Sep 2025Q2 FY26Mar 2026
Revenue152424241618141310999
Cost of revenue812101181210107666
Gross profit712131486433333
22911186859545
Research & development005072303010
12411−194556535
Selling & marketing11239−200007000
General & administrative112020003000
Other expenses0000290001000
Operating income51043−100−4−2−6−2−1−2
0001−100−1111−100
Interest income000100000000
Interest expense000000000000
Other non-operating income000−110011−11100
Income before tax51043−110−4−124−30−2
Income tax expense1202−11110000
Net income from continuing operations4742−11−1−5−134−30−2
Other adjustments000000000000
Net income4742−10−1−5−134−30−2
EPS, basic$647.85$1,355.80$791.38$292.37−$1,767.40−$120.79−$919.74−$2,155.91$719.79−$944.40−$0.69−$2.76
EPS, diluted$647.85$1,355.80$791.38$292.37−$1,767.40−$120.79−$919.74−$2,155.91$719.79−$944.40−$0.69−$2.76
Weighted average shares, basic000000000—11
Weighted average shares, diluted000000000—11
EBITDA51044−111−4−125−30−1
Depreciation & amortization000000000000
EBIT51043−110−4−124−30−2